Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shreekant Deshpande is active.

Publication


Featured researches published by Shreekant Deshpande.


Bioorganic & Medicinal Chemistry | 2009

Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents.

Ravi Shankar; Bandana Chakravarti; Uma Sharan Singh; Mohd. Imran Ansari; Shreekant Deshpande; Shailendra Kumar Dhar Dwivedi; Hemant Kumar Bid; Rituraj Konwar; Geetika Kharkwal; Vishal Chandra; Anila Dwivedi; Kanchan Hajela

A series of 3,4,6-triaryl-2-pyranones, new class of anti-breast cancer agents, have been synthesized as a structural variants of cyclic triphenylethylenes by replacing the fused benzene ring with pendant phenyl ring to mimic the phenolic A ring of estradiol. Nine of these newly synthesized pyranones exhibited significant anti-proliferative activity in both ER+ve and ER-ve breast cancer cell lines. Four active non-cytotoxic compounds 5c, 5d, 5g and 5h showed specific and selective cytotoxicity and two compounds 5d and 5h induced significant DNA fragmentation in both MCF-7 and MDA-MB-231 cell lines. Based on RBA studies, the molecules probably act in an ER-independent mechanism. The involved pathway was observed as caspase-dependant apoptosis in MCF-7 cells. However, the particular caspases involved and the possible cellular target through which this series of compounds mediate cell death are not known.


Toxicological Sciences | 2012

Cypermethrin Induces Astrocyte Apoptosis by the Disruption of the Autocrine/Paracrine Mode of Epidermal Growth Factor Receptor Signaling

Shailendra Kumar Maurya; Asit Rai; Nagendra Kumar Rai; Shreekant Deshpande; Rajeev Jain; Mohana Krishna Reddy Mudiam; Yenamandra S. Prabhakar; Sanghamitra Bandyopadhyay

Cypermethrin is reported to affect astrocytes in rat brain; however, its mechanism of action is obscure. Here, we observed an increase in apoptosis in the cortical astrocytes upon treatment of rats with cypermethrin. We then characterized the mechanism governing the apoptosis. Because the epidermal growth factor receptor (EGFR) signaling regulates the survival of astrocytes, we investigated the effect of cypermethrin on EGFR activation. The astrocytes exhibited an early and irreversible attenuation in the basal EGFR phosphorylation. Supportively, molecular docking studies revealed considerable homology in the docking mode of cypermethrin and the known EGFR inhibitors, erlotinib and AG1478, to the kinase domain of EGFR. Furthermore, treatment with cypermethrin demonstrated a downregulation in the intracellular and secreted levels of heparin-binding epidermal growth factor (HB-EGF), an EGFR ligand. AG1478 reduced the synthesis of HB-EGF, suggesting the dependence of HB-EGF on EGFR activation. In addition, a neutralizing antibody against HB-EGF diminished the basal EGFR levels, indicating ligand-dependent expression of EGFR. Likewise, cypermethrin caused irreversible suppression in the basal EGFR levels, which induced apoptosis in astrocytes. The apoptosis was prevented by exogenous HB-EGF. These data imply an autocrine/paracrine mode of action of HB-EGF-EGFR in astrocyte survival. Consequently, cypermethrin induced a mitochondria-mediated apoptosis, characterized by rise in Bax/Bcl-2 ratio and cleavage of caspase-9, -3, and -7, and the effect was prevented by HB-EGF. HB-EGF activated the extracellular signal-regulated kinases and AKT pathways that protected against apoptosis. Together, these data demonstrate that cypermethrin induces astrocyte apoptosis by disrupting the autocrine/paracrine mode of HB-EGF-EGFR signaling at two levels, irreversible loss of basal EGFR and downregulation of HB-EGF.


Molecular and Cellular Endocrinology | 2011

Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.

Bandana Chakravarti; Jawed A. Siddiqui; Shailendra Kumar Dhar Dwivedi; Shreekant Deshpande; Krishnanda Samanta; Rabi S. Bhatta; Gautam Panda; Yenamandra S. Prabhakar; Rituraj Konwar; Sabaysachi Sanyal; Naibedya Chattopadhyay

The present study sought to investigate the in vitro and in vivo effects of a tyrosine-based benzoxazepine, 4-[4-(toluene-4-sulfonyl)-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-3-ylmethyl]-phenol) [THBP] in human breast cancer cells, with a focus on determining its molecular target. THBP had growth inhibitory effect on MCF-7 and MDA-MD-231 cells. At IC(50) value (∼20 μM), THBP resulted in G1 arrest, decrease in cyclin D1 levels and induction of apoptosis of MCF-7 cells. Mechanistically, activation of caspase 8 contributes critically to the induction of apoptotic cell death as copresence of selective inhibition of caspase 8 effectively abrogates the cytotoxic effect of THBP in MCF-7 cells. Further, THBP increased pro-apoptotic protein, Bax; decreased anti-apoptotic protein, Bcl-2; and decreased mitochondrial membrane potential in MCF-7 cells, indicating involvement of an intrinsic pathway of apoptosis following caspase 8 activation. Out of the various growth factors/hormones, THBP selectively abrogated increased viability of MCF-7 cells by insulin-like growth factor 1 (IGF-1). Molecular docking studies revealed that THBP occupied the ATP binding pocket of IGF-1 receptor (IGF-1R). Accordingly THBP was found to inhibit IGF-1-induced phosphorylation of IGF-1R and insulin receptor substrate-1 (IRS-1) without inhibiting insulin signaling in MCF-7 cells. In athymic nude mice, compared with vehicle, THBP treatment significantly reduced the growth of MCF-7 xenograft tumors through inhibition of cancer cell proliferation as well as promotion of cell death that correlated with reduced phospho-IGF-1R levels. We suggest that interfering with the IGF-1R signaling by the benzoxazepine THBP offers a novel and selective therapeutic strategy for estrogen receptor-positive, postmenopausal breast cancer patients.


Journal of Enzyme Inhibition and Medicinal Chemistry | 2009

Topological descriptors in modelling antimalarial activity: N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine as prototype

Shreekant Deshpande; V. Raja Solomon; Setu B. Katti; Yenamandra S. Prabhakar

The QSAR of antimalarial activity of two distinct series of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl) piperazine analogues are investigated with DRAGON descriptors in order to rationalize their activity. Of these two series of compounds, one has amide characteristics and the other has amine characteristics. Both the analogues have shared radial centric information (ICR) as common modelling descriptor with increased centricity in the molecules as preferred feature for antimalarial activity. Apart from this, the models of amide analogues suggested in favor of distantly placed nitrogen(s) and unfavorable nature of carbonyl moieties adjacent to nitrogen in the varying portion of the molecule for the activity. Moreover, for these analogues, the regression models have preferred the lone pair electrons on heteroatoms (N and O) for purposes other than H-bonds for better activity. In case of amine analogues, the models suggested in favor of compact structural moieties in the varying parts of the molecule for improved activity. Also, for these analogues, hydrophobicity of the compound is an important factor for influencing activity. The variations in the models of amide and amine analogues are attributed to the characteristic functional differences of these analogues.


Bioorganic & Medicinal Chemistry | 2009

Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer☆

Shailesh Kumar; Shreekant Deshpande; Vishal Chandra; Shakti Kitchlu; Anila Dwivedi; Vadithe Lakshma Nayak; Rituraj Konwar; Yenamandra S. Prabhakar; Devi Prasad Sahu

A novel class of 2,3,4-triarylbenzopyrans has been synthesized and were evaluated for their selective estrogen receptor modulation activity and as a therapeutic agent for breast cancer. Among the compounds synthesized, compounds 11a and 12c exhibited 73.91% and 69.24% inhibition as estrogen antagonistic activity, respectively. Compound 12a showed the lowest IC(50) at 6.97 microM against MCF-7 and 11f showed the lowest IC(50) value of 5.6 microM against MDA-MB-231 cell line in spite of their low receptor binding affinity implicating these compounds probably act through ER independent mechanism.


Sar and Qsar in Environmental Research | 2011

CoMFA and CoMSIA analysis of tetrahydroquinolines as potential antimalarial agents

Shreekant Deshpande; Srishti Jaiswal; S. B. Katti; Yenamandra S. Prabhakar

Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were used on a dataset of compounds, some of them having been reported to inhibit Plasmodium falciparum protein, farnesyltransferase. The co-crystal structure of the lead molecule, BMS–214662 bound to Rat-PFT was used as a template. CoMFA yielded a good model, with  = 0.909,  = 0.617 and was validated using an external set (  = 0.748). It compared favourably with CoMSIA. In the CoMFA model the steric and electrostatic fields exerted an almost equal influence on activity. The contour maps indicated the necessity for sterically large electropositive groups with electronegative tail to be present in these molecules for activity, and sterically large electronegative moieties on the sulfonamide linker. By incorporating these features some new compounds have been identified for further investigation.


Journal of Enzyme Inhibition and Medicinal Chemistry | 2011

Consensus features of CP-MLR and GA in modeling HIV-1 RT inhibitory activity of 4-benzyl/benzoylpyridin-2-one analogues

Shreekant Deshpande; Rinki Singh; Mohammad Goodarzi; S. B. Katti; Yenamandra S. Prabhakar

The HIV-1 reverse transcriptase (RT) inhibitory activity of benzyl/benzoylpyridinones is modeled with molecular features identified in combinatorial protocol in multiple linear regression (CP-MLR) and genetic algorithm (GA). Among the features, nDB and LogP are found to be the most influential descriptors to modulate the activity. Although the coefficient of nDB suggested in favor of benzylpyridinones skeleton, the coefficient of LogP suggested the favorability of hydrophilic nature in compounds for better activity. The partial least squares analysis of the descriptors common to CP-MLR and GA has displayed their predictivity over the total descriptors identified in both the approaches. The back-propagation artificial neural networks model from the five most significant common descriptors (nDB, T(O..O), MATS8e, LogP, and BELp4) has explained 93.2% variance in the HIV-1 RT activity of the training set compounds and showed a test set r2 of 0.89. The results suggest that the descriptors have the ability to identify the patterns in the compounds to predict potential analogues.


Qsar & Combinatorial Science | 2009

Is Feature Selection Essential for ANN Modeling

Mohammad Goodarzi; Shreekant Deshpande; Vanangamudi Murugesan; S. B. Katti; Yenamandra S. Prabhakar


Archive | 2010

Multi-Model Environment as a Rational Approach for Drug Design: An Experience with CP-MLR

Shreekant Deshpande; Manish K. Gupta; Yenamandra S. Prabhakar


The Natural Products Journal | 2017

Synthesis and Bio-evaluation of 7-trifluromethyl Substituted 4-aminoquinoline Derivatives as Antileishmanial Agents

Shreekant Deshpande; Rahul Shivahare; Utsab Debnath; Shraddha A. Sane; Suman Gupta; S. B. Katti

Collaboration


Dive into the Shreekant Deshpande's collaboration.

Top Co-Authors

Avatar

Yenamandra S. Prabhakar

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

S. B. Katti

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Rituraj Konwar

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Mohammad Goodarzi

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Anila Dwivedi

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Bandana Chakravarti

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vishal Chandra

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Asit Rai

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

Devi Prasad Sahu

Central Drug Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge